APO Research
Talk to an analyst

APO RESEARCH · REPORT

Escitalopram Oxalate

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Escitalopram Oxalate Industry Growth and Trends Forecast to 2032

31 December 202599 pages

Choose your research edition.

Industry ResearchEscitalopram Oxalate Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Escitalopram Oxalate Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Escitalopram Oxalate Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Escitalopram Oxalate Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Escitalopram Oxalate Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Escitalopram Oxalate market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Escitalopram Oxalate is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Escitalopram Oxalate is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Escitalopram Oxalate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Escitalopram Oxalate include Dr Reddy's, Nishchem International Pvt, JEWIM PHARMA, Ke Lun, Xian.-Janssen and HUAHAI PHARMACEUTICAL, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Escitalopram Oxalate market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Escitalopram Oxalate market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Escitalopram Oxalate market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Escitalopram Oxalate.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Escitalopram Oxalate market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Escitalopram Oxalate Market by Company

Dr Reddy's

Nishchem International Pvt

JEWIM PHARMA

Ke Lun

Xian.-Janssen

HUAHAI PHARMACEUTICAL

Escitalopram Oxalate Segment by Type

Oral Liquid

Tablet

Other

Escitalopram Oxalate Segment by Application

Treat Depression

Treat Obsessive-Compulsive Disorder

Treat Anxiety

Others

Escitalopram Oxalate Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Escitalopram Oxalate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Escitalopram Oxalate and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Escitalopram Oxalate.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Escitalopram Oxalate manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Escitalopram Oxalate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Oral Liquid Table 2. Major Company of Tablet Table 3. Major Company of Other Table 4. Global Escitalopram Oxalate Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Escitalopram Oxalate Sales by Type (2021-2026) & (K Units) Table 6. Global Escitalopram Oxalate Sales Market Share in Volume by Type (2021-2026) Table 7. Global Escitalopram Oxalate Sales by Type (2021-2026) & (US$ Million) Table 8. Global Escitalopram Oxalate Sales Market Share in Value by Type (2021-2026) Table 9. Global Escitalopram Oxalate Price by Type (2021-2026) & (US$/Unit) Table 10. Global Escitalopram Oxalate Sales by Type (2027-2032) & (K Units) Table 11. Global Escitalopram Oxalate Sales Market Share in Volume by Type (2027-2032) Table 12. Global Escitalopram Oxalate Sales by Type (2027-2032) & (US$ Million) Table 13. Global Escitalopram Oxalate Sales Market Share in Value by Type (2027-2032) Table 14. Global Escitalopram Oxalate Price by Type (2027-2032) & (US$/Unit) Table 15. North America Escitalopram Oxalate Sales by Type (2021-2026) & (K Units) Table 16. North America Escitalopram Oxalate Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Escitalopram Oxalate Sales by Type (2021-2026) & (K Units) Table 18. Europe Escitalopram Oxalate Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Escitalopram Oxalate Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Escitalopram Oxalate Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Escitalopram Oxalate Sales by Type (2021-2026) & (K Units) Table 22. Latin America Escitalopram Oxalate Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Escitalopram Oxalate Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Escitalopram Oxalate Sales by Type (2021-2026) & (US$ Million) Table 25. Escitalopram Oxalate Industry Trends Table 26. Escitalopram Oxalate Industry Drivers Table 27. Escitalopram Oxalate Industry Opportunities and Challenges Table 28. Escitalopram Oxalate Industry Restraints Table 29. Global Escitalopram Oxalate Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Escitalopram Oxalate Revenue Market Share by Company (2021-2026) Table 31. Global Escitalopram Oxalate Sales by Company (2021-2026) & (K Units) Table 32. Global Escitalopram Oxalate Sales Share by Company (2021-2026) Table 33. Global Escitalopram Oxalate Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Escitalopram Oxalate Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Escitalopram Oxalate Major Company Production Sites and Headquarters Table 36. Global Escitalopram Oxalate Company, Product Type & Application Table 37. Global Escitalopram Oxalate Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Escitalopram Oxalate by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Escitalopram Oxalate Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Escitalopram Oxalate Sales by Region (2021-2026) & (K Units) Table 42. Global Escitalopram Oxalate Sales Market Share in Volume by Region (2021-2026) Table 43. Global Escitalopram Oxalate Sales by Region (2021-2026) & (US$ Million) Table 44. Global Escitalopram Oxalate Sales Market Share in Value by Region (2021-2026) Table 45. Global Escitalopram Oxalate Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Escitalopram Oxalate Sales by Region (2027-2032) & (K Units) Table 47. Global Escitalopram Oxalate Sales Market Share in Volume by Region (2027-2032) Table 48. Global Escitalopram Oxalate Sales by Region (2027-2032) & (US$ Million) Table 49. Global Escitalopram Oxalate Sales Market Share in Value by Region (2027-2032) Table 50. Global Escitalopram Oxalate Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Escitalopram Oxalate Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Escitalopram Oxalate Sales by Application (2021-2026) & (K Units) Table 53. Global Escitalopram Oxalate Sales Market Share in Volume by Application (2021-2026) Table 54. Global Escitalopram Oxalate Sales by Application (2021-2026) & (US$ Million) Table 55. Global Escitalopram Oxalate Sales Market Share in Value by Application (2021-2026) Table 56. Global Escitalopram Oxalate Price by Application (2021-2026) & (US$/Unit) Table 57. Global Escitalopram Oxalate Sales by Application (2027-2032) & (K Units) Table 58. Global Escitalopram Oxalate Sales Market Share in Volume by Application (2027-2032) Table 59. Global Escitalopram Oxalate Sales by Application (2027-2032) & (US$ Million) Table 60. Global Escitalopram Oxalate Sales Market Share in Value by Application (2027-2032) Table 61. Global Escitalopram Oxalate Price by Application (2027-2032) & (US$/Unit) Table 62. North America Escitalopram Oxalate Sales by Application (2021-2026) & (K Units) Table 63. North America Escitalopram Oxalate Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Escitalopram Oxalate Sales by Application (2021-2026) & (K Units) Table 65. Europe Escitalopram Oxalate Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Escitalopram Oxalate Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Escitalopram Oxalate Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Escitalopram Oxalate Sales by Application (2021-2026) & (K Units) Table 69. Latin America Escitalopram Oxalate Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Escitalopram Oxalate Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Escitalopram Oxalate Sales by Application (2021-2026) & (US$ Million) Table 72. Dr Reddy's Company Information Table 73. Dr Reddy's Business Overview Table 74. Dr Reddy's Escitalopram Oxalate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Dr Reddy's Escitalopram Oxalate Product Portfolio Table 76. Dr Reddy's Recent Development Table 77. Nishchem International Pvt Company Information Table 78. Nishchem International Pvt Business Overview Table 79. Nishchem International Pvt Escitalopram Oxalate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Nishchem International Pvt Escitalopram Oxalate Product Portfolio Table 81. Nishchem International Pvt Recent Development Table 82. JEWIM PHARMA Company Information Table 83. JEWIM PHARMA Business Overview Table 84. JEWIM PHARMA Escitalopram Oxalate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. JEWIM PHARMA Escitalopram Oxalate Product Portfolio Table 86. JEWIM PHARMA Recent Development Table 87. Ke Lun Company Information Table 88. Ke Lun Business Overview Table 89. Ke Lun Escitalopram Oxalate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Ke Lun Escitalopram Oxalate Product Portfolio Table 91. Ke Lun Recent Development Table 92. Xian.-Janssen Company Information Table 93. Xian.-Janssen Business Overview Table 94. Xian.-Janssen Escitalopram Oxalate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Xian.-Janssen Escitalopram Oxalate Product Portfolio Table 96. Xian.-Janssen Recent Development Table 97. HUAHAI PHARMACEUTICAL Company Information Table 98. HUAHAI PHARMACEUTICAL Business Overview Table 99. HUAHAI PHARMACEUTICAL Escitalopram Oxalate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. HUAHAI PHARMACEUTICAL Escitalopram Oxalate Product Portfolio Table 101. HUAHAI PHARMACEUTICAL Recent Development Table 102. North America Escitalopram Oxalate Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 103. North America Escitalopram Oxalate Sales by Country (2021-2026) & (K Units) Table 104. North America Escitalopram Oxalate Sales Market Share by Country (2021-2026) Table 105. North America Escitalopram Oxalate Sales Forecast by Country (2027-2032) & (K Units) Table 106. North America Escitalopram Oxalate Sales Market Share Forecast by Country (2027-2032) Table 107. North America Escitalopram Oxalate Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 108. North America Escitalopram Oxalate Market Size by Country (2021-2026) & (US$ Million) Table 109. North America Escitalopram Oxalate Market Share by Country (2021-2026) Table 110. North America Escitalopram Oxalate Market Size Forecast by Country (2027-2032) & (US$ Million) Table 111. North America Escitalopram Oxalate Market Share Forecast by Country (2027-2032) Table 112. Europe Escitalopram Oxalate Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 113. Europe Escitalopram Oxalate Sales by Country (2021-2026) & (K Units) Table 114. Europe Escitalopram Oxalate Sales Market Share by Country (2021-2026) Table 115. Europe Escitalopram Oxalate Sales Forecast by Country (2027-2032) & (K Units) Table 116. Europe Escitalopram Oxalate Sales Market Share Forecast by Country (2027-2032) Table 117. Europe Escitalopram Oxalate Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 118. Europe Escitalopram Oxalate Market Size by Country (2021-2026) & (US$ Million) Table 119. Europe Escitalopram Oxalate Market Share by Country (2021-2026) Table 120. Europe Escitalopram Oxalate Market Size Forecast by Country (2027-2032) & (US$ Million) Table 121. Europe Escitalopram Oxalate Market Share Forecast by Country (2027-2032) Table 122. Asia-Pacific Escitalopram Oxalate Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 123. Asia-Pacific Escitalopram Oxalate Sales by Country (2021-2026) & (K Units) Table 124. Asia-Pacific Escitalopram Oxalate Sales Market Share by Country (2021-2026) Table 125. Asia-Pacific Escitalopram Oxalate Sales Forecast by Country (2027-2032) & (K Units) Table 126. Asia-Pacific Escitalopram Oxalate Sales Market Share Forecast by Country (2027-2032) Table 127. Asia-Pacific Escitalopram Oxalate Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. Asia-Pacific Escitalopram Oxalate Market Size by Country (2021-2026) & (US$ Million) Table 129. Asia-Pacific Escitalopram Oxalate Market Share by Country (2021-2026) Table 130. Asia-Pacific Escitalopram Oxalate Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. Asia-Pacific Escitalopram Oxalate Market Share Forecast by Country (2027-2032) Table 132. Latin America Escitalopram Oxalate Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 133. Latin America Escitalopram Oxalate Sales by Country (2021-2026) & (K Units) Table 134. Latin America Escitalopram Oxalate Sales Market Share by Country (2021-2026) Table 135. Latin America Escitalopram Oxalate Sales Forecast by Country (2027-2032) & (K Units) Table 136. Latin America Escitalopram Oxalate Sales Market Share Forecast by Country (2027-2032) Table 137. Latin America Escitalopram Oxalate Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Latin America Escitalopram Oxalate Market Size by Country (2021-2026) & (US$ Million) Table 139. Latin America Escitalopram Oxalate Market Share by Country (2021-2026) Table 140. Latin America Escitalopram Oxalate Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Latin America Escitalopram Oxalate Market Share Forecast by Country (2027-2032) Table 142. Middle East and Africa Escitalopram Oxalate Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 143. Middle East and Africa Escitalopram Oxalate Sales by Country (2021-2026) & (K Units) Table 144. Middle East and Africa Escitalopram Oxalate Sales Market Share by Country (2021-2026) Table 145. Middle East and Africa Escitalopram Oxalate Sales Forecast by Country (2027-2032) & (K Units) Table 146. Middle East and Africa Escitalopram Oxalate Sales Market Share Forecast by Country (2027-2032) Table 147. Middle East and Africa Escitalopram Oxalate Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Middle East and Africa Escitalopram Oxalate Market Size by Country (2021-2026) & (US$ Million) Table 149. Middle East and Africa Escitalopram Oxalate Market Share by Country (2021-2026) Table 150. Middle East and Africa Escitalopram Oxalate Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Middle East and Africa Escitalopram Oxalate Market Share Forecast by Country (2027-2032) Table 152. Key Raw Materials Table 153. Raw Materials Key Suppliers Table 154. Escitalopram Oxalate Distributors List Table 155. Escitalopram Oxalate Customers List Table 156. Research Programs/Design for This Report Table 157. Authors List of This Report Table 158. Secondary Sources Table 159. Primary Sources List of Figures Figure 1. Escitalopram Oxalate Image Figure 2. Global Escitalopram Oxalate Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Escitalopram Oxalate Market Size (2021-2032) & (US$ Million) Figure 4. Global Escitalopram Oxalate Sales (2021-2032) & (K Units) Figure 5. Oral Liquid Image Figure 6. Global Oral Liquid Sales YoY Growth (2021-2032) & (K Units) Figure 7. Tablet Image Figure 8. Global Tablet Sales YoY Growth (2021-2032) & (K Units) Figure 9. Other Image Figure 10. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Escitalopram Oxalate Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Escitalopram Oxalate Market Share by Type 2025 VS 2032 Figure 13. North America Escitalopram Oxalate Sales Market Share in Volume by Type in 2025 Figure 14. North America Escitalopram Oxalate Sales Market Share in Value by Type in 2025 Figure 15. Europe Escitalopram Oxalate Sales Market Share in Volume by Type in 2025 Figure 16. Europe Escitalopram Oxalate Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Escitalopram Oxalate Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Escitalopram Oxalate Sales Market Share in Value by Type in 2025 Figure 19. Latin America Escitalopram Oxalate Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Escitalopram Oxalate Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Escitalopram Oxalate Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Escitalopram Oxalate Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Escitalopram Oxalate Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Treat Depression Image Figure 26. Global Treat Depression Sales YoY Growth (2021-2032) & (K Units) Figure 27. Treat Obsessive-Compulsive Disorder Image Figure 28. Global Treat Obsessive-Compulsive Disorder Sales YoY Growth (2021-2032) & (K Units) Figure 29. Treat Anxiety Image Figure 30. Global Treat Anxiety Sales YoY Growth (2021-2032) & (K Units) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global Escitalopram Oxalate Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Escitalopram Oxalate Market Share by Application 2025 VS 2032 Figure 35. North America Escitalopram Oxalate Sales Market Share in Volume by Application in 2025 Figure 36. North America Escitalopram Oxalate Sales Market Share in Value by Application in 2025 Figure 37. Europe Escitalopram Oxalate Sales Market Share in Volume by Application in 2025 Figure 38. Europe Escitalopram Oxalate Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Escitalopram Oxalate Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Escitalopram Oxalate Sales Market Share in Value by Application in 2025 Figure 41. Latin America Escitalopram Oxalate Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Escitalopram Oxalate Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Escitalopram Oxalate Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Escitalopram Oxalate Sales Market Share in Value by Application in 2025 Figure 45. North America Escitalopram Oxalate Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America Escitalopram Oxalate Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Escitalopram Oxalate Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Escitalopram Oxalate Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Escitalopram Oxalate Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe Escitalopram Oxalate Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Escitalopram Oxalate Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Escitalopram Oxalate Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Escitalopram Oxalate Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific Escitalopram Oxalate Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Escitalopram Oxalate Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Escitalopram Oxalate Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Escitalopram Oxalate Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America Escitalopram Oxalate Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Escitalopram Oxalate Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Escitalopram Oxalate Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Escitalopram Oxalate Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa Escitalopram Oxalate Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Escitalopram Oxalate Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Escitalopram Oxalate Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Escitalopram Oxalate Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Escitalopram Oxalate Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Oral Liquid
  • Tablet
  • Other
Applications
  • Treat Depression
  • Treat Obsessive-Compulsive Disorder
  • Treat Anxiety
  • Others
Companies covered
  • Dr Reddy's
  • Nishchem International Pvt
  • JEWIM PHARMA
  • Ke Lun
  • Xian.-Janssen
  • HUAHAI PHARMACEUTICAL

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Escitalopram Oxalate Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Escitalopram Oxalate Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Escitalopram Oxalate Market by Type
  6. 1.3.1 Oral Liquid
  7. 1.3.2 Tablet
  8. 1.3.3 Other
  9. 1.4 Global Escitalopram Oxalate Market Size by Type
  10. 1.4.1 Global Escitalopram Oxalate Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Escitalopram Oxalate Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Escitalopram Oxalate Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Escitalopram Oxalate Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Escitalopram Oxalate Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Escitalopram Oxalate Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Escitalopram Oxalate Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Escitalopram Oxalate Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Escitalopram Oxalate Industry Trends
  2. 2.2 Escitalopram Oxalate Industry Drivers
  3. 2.3 Escitalopram Oxalate Industry Opportunities and Challenges
  4. 2.4 Escitalopram Oxalate Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Escitalopram Oxalate Revenue (2021-2026)
  2. 3.2 Global Top Players by Escitalopram Oxalate Sales (2021-2026)
  3. 3.3 Global Top Players by Escitalopram Oxalate Price (2021-2026)
  4. 3.4 Global Escitalopram Oxalate Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Escitalopram Oxalate Major Company Production Sites & Headquarters
  6. 3.6 Global Escitalopram Oxalate Company, Product Type & Application
  7. 3.7 Global Escitalopram Oxalate Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Escitalopram Oxalate Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Escitalopram Oxalate Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Escitalopram Oxalate Tier 1, Tier 2, and Tier 3
4 Escitalopram Oxalate Regional Status and Outlook
  1. 4.1 Global Escitalopram Oxalate Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Escitalopram Oxalate Historic Market Size by Region
  3. 4.2.1 Global Escitalopram Oxalate Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Escitalopram Oxalate Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Escitalopram Oxalate Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Escitalopram Oxalate Forecasted Market Size by Region
  7. 4.3.1 Global Escitalopram Oxalate Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Escitalopram Oxalate Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Escitalopram Oxalate Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Escitalopram Oxalate by Application
  1. 5.1 Escitalopram Oxalate Market by Application
  2. 5.1.1 Treat Depression
  3. 5.1.2 Treat Obsessive-Compulsive Disorder
  4. 5.1.3 Treat Anxiety
  5. 5.1.4 Others
  6. 5.2 Global Escitalopram Oxalate Market Size by Application
  7. 5.2.1 Global Escitalopram Oxalate Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Escitalopram Oxalate Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Escitalopram Oxalate Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Escitalopram Oxalate Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Escitalopram Oxalate Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Escitalopram Oxalate Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Escitalopram Oxalate Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Escitalopram Oxalate Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Dr Reddy's
  2. 6.1.1 Dr Reddy's Company Information
  3. 6.1.2 Dr Reddy's Business Overview
  4. 6.1.3 Dr Reddy's Escitalopram Oxalate Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Dr Reddy's Escitalopram Oxalate Product Portfolio
  6. 6.1.5 Dr Reddy's Recent Developments
  7. 6.2 Nishchem International Pvt
  8. 6.2.1 Nishchem International Pvt Company Information
  9. 6.2.2 Nishchem International Pvt Business Overview
  10. 6.2.3 Nishchem International Pvt Escitalopram Oxalate Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Nishchem International Pvt Escitalopram Oxalate Product Portfolio
  12. 6.2.5 Nishchem International Pvt Recent Developments
  13. 6.3 JEWIM PHARMA
  14. 6.3.1 JEWIM PHARMA Company Information
  15. 6.3.2 JEWIM PHARMA Business Overview
  16. 6.3.3 JEWIM PHARMA Escitalopram Oxalate Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 JEWIM PHARMA Escitalopram Oxalate Product Portfolio
  18. 6.3.5 JEWIM PHARMA Recent Developments
  19. 6.4 Ke Lun
  20. 6.4.1 Ke Lun Company Information
  21. 6.4.2 Ke Lun Business Overview
  22. 6.4.3 Ke Lun Escitalopram Oxalate Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Ke Lun Escitalopram Oxalate Product Portfolio
  24. 6.4.5 Ke Lun Recent Developments
  25. 6.5 Xian.-Janssen
  26. 6.5.1 Xian.-Janssen Company Information
  27. 6.5.2 Xian.-Janssen Business Overview
  28. 6.5.3 Xian.-Janssen Escitalopram Oxalate Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Xian.-Janssen Escitalopram Oxalate Product Portfolio
  30. 6.5.5 Xian.-Janssen Recent Developments
  31. 6.6 HUAHAI PHARMACEUTICAL
  32. 6.6.1 HUAHAI PHARMACEUTICAL Company Information
  33. 6.6.2 HUAHAI PHARMACEUTICAL Business Overview
  34. 6.6.3 HUAHAI PHARMACEUTICAL Escitalopram Oxalate Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 HUAHAI PHARMACEUTICAL Escitalopram Oxalate Product Portfolio
  36. 6.6.5 HUAHAI PHARMACEUTICAL Recent Developments
7 North America by Country
  1. 7.1 North America Escitalopram Oxalate Sales by Country
  2. 7.1.1 North America Escitalopram Oxalate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Escitalopram Oxalate Sales by Country (2021-2026)
  4. 7.1.3 North America Escitalopram Oxalate Sales Forecast by Country (2027-2032)
  5. 7.2 North America Escitalopram Oxalate Market Size by Country
  6. 7.2.1 North America Escitalopram Oxalate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Escitalopram Oxalate Market Size by Country (2021-2026)
  8. 7.2.3 North America Escitalopram Oxalate Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Escitalopram Oxalate Sales by Country
  2. 8.1.1 Europe Escitalopram Oxalate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Escitalopram Oxalate Sales by Country (2021-2026)
  4. 8.1.3 Europe Escitalopram Oxalate Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Escitalopram Oxalate Market Size by Country
  6. 8.2.1 Europe Escitalopram Oxalate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Escitalopram Oxalate Market Size by Country (2021-2026)
  8. 8.2.3 Europe Escitalopram Oxalate Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Escitalopram Oxalate Sales by Country
  2. 9.1.1 Asia-Pacific Escitalopram Oxalate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Escitalopram Oxalate Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Escitalopram Oxalate Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Escitalopram Oxalate Market Size by Country
  6. 9.2.1 Asia-Pacific Escitalopram Oxalate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Escitalopram Oxalate Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Escitalopram Oxalate Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Escitalopram Oxalate Sales by Country
  2. 10.1.1 South America Escitalopram Oxalate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Escitalopram Oxalate Sales by Country (2021-2026)
  4. 10.1.3 South America Escitalopram Oxalate Sales Forecast by Country (2027-2032)
  5. 10.2 South America Escitalopram Oxalate Market Size by Country
  6. 10.2.1 South America Escitalopram Oxalate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Escitalopram Oxalate Market Size by Country (2021-2026)
  8. 10.2.3 South America Escitalopram Oxalate Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Escitalopram Oxalate Sales by Country
  2. 11.1.1 Middle East and Africa Escitalopram Oxalate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Escitalopram Oxalate Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Escitalopram Oxalate Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Escitalopram Oxalate Market Size by Country
  6. 11.2.1 Middle East and Africa Escitalopram Oxalate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Escitalopram Oxalate Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Escitalopram Oxalate Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Escitalopram Oxalate Value Chain Analysis
  2. 12.1.1 Escitalopram Oxalate Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Escitalopram Oxalate Production Mode & Process
  7. 12.2 Escitalopram Oxalate Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Escitalopram Oxalate Distributors
  10. 12.2.3 Escitalopram Oxalate Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst